Corneal cross-linking versus standard care in children with keratoconus – a randomised, multicentre, observer-masked trial of efficacy and safety (KERALINK): a statistical analysis plan | Trials | Full Text

Corneal cross-linking versus standard care in children with keratoconus – a randomised, multicentre, observer-masked trial of efficacy and safety (KERALINK): a statistical analysis plan | Trials | Full Text

Corneal cross-linking versus standard care in children with keratoconus – a randomised, multicentre, observer-masked trial of efficacy and safety (KERALINK): a statistical analysis plan

The KERALINK trial tests the hypothesis that corneal cross-linking (CXL) treatment reduces the progression of keratoconus in comparison to standard care in patients aged 10–16 years. This article describes the...

Authors:Kashfia Chowdhury, Caroline J. Doré, Catey Bunce and Daniel F. P. Larkin

Citation:Trials 2020 21:523

Content type:Update

 

Published on: 12 June 2020

• ViewFull Text
 
• ViewPDF